A Multicenter, Prospective, Randomized, Controlled Study to Evaluate the Efficacy of Addition of Alogliptin to the Alpha-glucosidase Inhibitors on Glycemic Control in Patients with Type 2 Diabetes mellitus Showing Inadequate Response to Alpha-glucosidase Inhibitors.
Phase of Trial: Phase II
Latest Information Update: 26 Nov 2015
At a glance
- Drugs Alogliptin (Primary) ; Alpha-glucosidase inhibitors
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 26 Nov 2015 New trial record